BIOMAT Database Logo BIOMAT Database Logo

Effect of deflazacort on bone mineral density in renal transplant recipients. 1998

M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Department of Surgery, Yonsei University Wonju College of Medicine, Ilsan-dong, Wonju, Korea.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011282 Pregnenediones Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures. Diketopregnenes,Dioxopregnenes
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral

Related Publications

M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Bisphosphonates can improve bone mineral density in renal transplant recipients.
December 2006, Nature clinical practice. Nephrology,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Statin use and bone mineral density in renal transplant recipients.
October 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Effect of chronic hepatitis C virus infection on bone mineral density in pediatric renal transplant recipients.
September 2013, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Bone mineral density in pediatric transplant recipients.
August 2003, Transplantation,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Bone mineral density in kidney transplant recipients.
January 2001, Transplantation proceedings,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Relationship between leptin and bone mineral density in renal transplant recipients.
September 2005, Transplantation proceedings,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Resistance exercise training restores bone mineral density in renal transplant recipients.
January 2017, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Alendronate increases bone mineral density in long-term renal transplant recipients.
September 2002, Transplantation proceedings,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients.
January 2013, PloS one,
M S Kim, and Y S Kim, and S K Lim, and S I Kim, and J I Moon, and K Park
The correlation between sclerostin and bone mineral density in renal transplant recipients.
January 2020, Nefrologia,
Copied contents to your clipboard!